Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells

International Journal of Molecular Medicine

Volumn 23, Issue 2, 2009, Pages 205-209

  Ju, Donghung ^a   Wang, Xiaogang ^a   Xie, Youming ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alverine citrate; Combined therapy; Dyclonine; Proteasome; Proteasome inhibitor; Yeast genetics

Indexed keywords

ALVERINE CITRATE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DYCLONINE; ALVERINE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; ENZYME INHIBITOR; LEUPEPTIN; PROPIOPHENONE DERIVATIVE; PROPYLAMINE; PROTEASOME;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; BREAST TUMOR; DRUG ANTAGONISM; FEMALE; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME INHIBITORS; FEMALE; HUMANS; LEUPEPTINS; PROPIOPHENONES; PROPYLAMINES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 64749095015     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000118     Document Type: Article

References (20)

1. Hershko A, Ciechanover A and Varshavsky A: The ubiquitin system. Nat Med 10: 1073-1081, 2000.
2. Schwartz AL and Ciechanover A: The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50: 57-74, 1999.
3. Orlowski RZ and Kuhn DJ: Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 14: 1649-1657, 2008.
4. Milano A, Iaffaioli RV and Caponigro F: The proteasome: a worthwhile target for the treatment of solid tumours? Eur J Cancer 43: 1125-1133, 2007.
5. Voges D, Zwickl P and Baumeister W: The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68: 1015-1068, 1999.
6. Mannhaupt G, Schnall R, Karpov V, Vetter I and Feldmann H: Rpn4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast. FEBS Lett 450: 27-34, 1999.
7. Xie Y and Varshavsky A: RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit. Proc Natl Acad Sci USA 98: 3056-3061, 2001.
8. Ju D, Wang L, Mao X and Xie Y: Homeostatic regulation of the proteasome via an Rpn4-dependent feedback circuit. Biochem Biophys Res Commun 321: 51-57, 2004.
9. London M, Keck BI, Ramos PC and Dohmen RJ: Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome. FEBS Lett 567: 259-264, 2004.
10. Pan X, Ye P, Yuan DS, et al: A DNA integrity network in the yeast Saccharomyces cerevisiae. Cell 124: 1069-1081, 2006.
11. Tong AH, Lesage G, Bader GD, et al: Global mapping of the yeast genetic interaction network. Science 303: 808-813, 2004.
12. Lees ND, Skaggs B, Kirsch DR and Bard M: Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae - a review. Lipids 30: 221-226, 1995.
13. 14-reductase in human cholesterol biosynthesis. Biochim Biophys Acta 1761: 677-68, 2006.
14. Holmer L, Pezhman A and Worman HJ: The human lamin B receptor/sterol reductase multigene family. Genomics 54: 469-476, 1998.
15. Giaever G, Flaherty P, Kumm J, et al: Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci USA 101: 793-798, 2004.
16. Boersma AW, Nooter K, Oostrum RG and Stoter G: Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 24: 123-130, 1996.
17. Hillenmeyer ME, Fung E, Wildenhain J, et al: The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320: 362-365, 2008.
18. Xu H, Ju D, Jarois T and Xie Y: Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Breast Cancer Res Treat 107: 267-274, 2008.
19. Meusser B, Hirsch C, Jarosch E and Sommer T: ERAD: the long road to destruction. Nat Cell Biol 7: 766-772, 2005.
20. Goldstein JL, DeBose-Boyd RA and Brown MS: Protein sensors for membrane sterols. Cell 124: 35-46, 2006.